(S)-Warfarin

DB14055InvestigationalSmall molecule

Warfarin consists of a racemic mixture of two active enantiomers—R- and S- forms—each of which is cleared by different pathways. S-warfarin is 2-5 times more potent than the R-isomer in...

Mechanism: Pharmacologically active on Vitamin K epoxide reductase complex subunit 1
Curator reviewed
Formula / weight: C₁₉H₁₆O₄ · 308.3279 g/mol (avg)
Also known as: (-)-Warfarin · Levrowarfarin · S-Warfarin

Resolves to

Compound

UNIIHP31W7FNP4CAS5543-57-7ChEMBLCHEMBL251074ChEBI87738

Structure

InChIKeyPJVWKTKQMONHTI-HNNXBMFYSA-NSMILESCC(=O)C[C@@H](C1=CC=CC=C1)C1=C(O)C2=C(OC1=O)C=CC=C2

Targets

Q9BQB6VKORC1

What you can answer from here — as of July 12, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1,686Drug interactionsStructured to mechanism, not free text

3Clinical trialsPhase, status and sponsor resolved per trial

22+ReferencesStructured and connected to the statements they support

Which drugs share a target with (S)-Warfarin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account